newsfilter
← Latest News
Business Wire·

Cyteir Therapeutics Announces Pricing of Initial Public Offering

Cyteir Therapeutics, Inc. ("Cyteir") (NASDAQ:CYT), a company focused on the discovery and development of next-generation synthetically lethal therapies for cancer, today announced the pricing of its initial public offering of 7,400,000 shares of its com